Sunshine Biopharma, Inc. operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates through Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products segments. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.
Metrics to compare | SBFM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSBFMPeersSector | |
---|---|---|---|---|
P/E Ratio | −1.4x | −0.5x | −0.5x | |
PEG Ratio | −0.02 | −0.01 | 0.00 | |
Price/Book | 0.3x | 1.7x | 2.6x | |
Price / LTM Sales | 0.2x | 4.2x | 3.2x | |
Upside (Analyst Target) | 357.5% | 72.1% | 41.7% | |
Fair Value Upside | Unlock | 24.7% | 6.1% | Unlock |